|
Originally published In Press as doi:10.1074/jbc.M508211200 on December 16, 2005
J. Biol. Chem., Vol. 281, Issue 11, 7294-7301, March 17, 2006
TRP-ML1 Regulates Lysosomal pH and Acidic Lysosomal Lipid Hydrolytic Activity*
Abigail A. Soyombo ,
Sandra Tjon-Kon-Sang ,
Youssef Rbaibi ,
Enkelejda Bashllari ,
Jill Bisceglia ,
Shmuel Muallem 1, and
Kirill Kiselyov
From the
Department of Physiology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 and Department of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15260
Mucolipidosis type IV (MLIV) is caused by mutations in the ion channel mucolipin 1 (TRP-ML1). MLIV is typified by accumulation of lipids and membranous materials in intracellular organelles, which was hypothesized to be caused by the altered membrane fusion and fission events. How mutations in TRP-ML1 lead to aberrant lipolysis is not known. Here we present evidence that MLIV is a metabolic disorder that is not associated with aberrant membrane fusion/fission events. Thus, measurement of lysosomal pH revealed that the lysosomes in TRP-ML1-/- cells obtained from the patients with MLIV are over-acidified. TRP-ML1 can function as a H+ channel, and the increased lysosomal acidification in TRP-ML1-/- cells is likely caused by the loss of TRP-ML1-mediated H+ leak. Measurement of lipase activity using several substrates revealed a marked reduction in lipid hydrolysis in TRP-ML1-/- cells, which was rescued by the expression of TRP-ML1. Cell fractionation indicated specific loss of acidic lipase activity in TRP-ML1-/- cells. Furthermore, dissipation of the acidic lysosomal pH of TRP-ML1-/- cells by nigericin or chloroquine reversed the lysosomal storage disease phenotype. These findings provide a new mechanism to account for the pathogenesis of MLIV.
Received for publication, July 27, 2005
, and in revised form, December 14, 2005.
* This work was supported in part by National Institutes of Health Grants DE12309 and DK38938 (to S. M), a Mucolipidosis Foundation grant (to A. A. S.), and the Pittsburgh Life Science Greenhouse startup fund (to K. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Dept. of Physiology, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9040. Tel.: 214-645-6008; E-mail: shmuel.muallem{at}utsouthwestern.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Puertollano and K. Kiselyov
TRPMLs: in sickness and in health
Am J Physiol Renal Physiol,
June 1, 2009;
296(6):
F1245 - F1254.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. E. DeCoursey
Voltage-gated proton channels: what's next?
J. Physiol.,
November 15, 2008;
586(22):
5305 - 5324.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Vergarajauregui, P. S. Connelly, M. P. Daniels, and R. Puertollano
Autophagic dysfunction in mucolipidosis type IV patients
Hum. Mol. Genet.,
September 1, 2008;
17(17):
2723 - 2737.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Goldin, R. C. Caruso, W. Benko, C. R. Kaneski, S. Stahl, and R. Schiffmann
Isolated Ocular Disease Is Associated with Decreased Mucolipin-1 Channel Conductance
Invest. Ophthalmol. Vis. Sci.,
July 1, 2008;
49(7):
3134 - 3142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Miedel, Y. Rbaibi, C. J. Guerriero, G. Colletti, K. M. Weixel, O. A. Weisz, and K. Kiselyov
Membrane traffic and turnover in TRP-ML1-deficient cells: a revised model for mucolipidosis type IV pathogenesis
J. Exp. Med.,
June 9, 2008;
205(6):
1477 - 1490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Numata and Y. Okada
Proton Conductivity through the Human TRPM7 Channel and Its Molecular Determinants
J. Biol. Chem.,
May 30, 2008;
283(22):
15097 - 15103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Desai and J. Hu
Light Induces Peroxisome Proliferation in Arabidopsis Seedlings through the Photoreceptor Phytochrome A, the Transcription Factor HY5 HOMOLOG, and the Peroxisomal Protein PEROXIN11b
Plant Physiology,
March 1, 2008;
146(3):
1117 - 1127.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Xu, M. Delling, L. Li, X. Dong, and D. E. Clapham
Activating mutation in a mucolipin transient receptor potential channel leads to melanocyte loss in varitint-waddler mice
PNAS,
November 13, 2007;
104(46):
18321 - 18326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Zhang and P.-L. Li
Reconstitution and Characterization of a Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP)-sensitive Ca2+ Release Channel from Liver Lysosomes of Rats
J. Biol. Chem.,
August 31, 2007;
282(35):
25259 - 25269.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Miedel, Y. Rbaibi, K. Kiselyov, and O. A. Weisz
Uncovering the role of mucolipin-1 in the pathogenesis of the lysosomal storage disease mucolipidosis type IV
FASEB J,
April 1, 2007;
21(5):
A548 - A548.
|
 |
|

|
 |

|
 |
 
B. Nilius, G. Owsianik, T. Voets, and J. A. Peters
Transient Receptor Potential Cation Channels in Disease
Physiol Rev,
January 1, 2007;
87(1):
165 - 217.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Jennings Jr., J.-h. Zhu, Y. Rbaibi, X. Luo, C. T. Chu, and K. Kiselyov
Mitochondrial Aberrations in Mucolipidosis Type IV
J. Biol. Chem.,
December 22, 2006;
281(51):
39041 - 39050.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Venkatachalam, T. Hofmann, and C. Montell
Lysosomal Localization of TRPML3 Depends on TRPML2 and the Mucolipidosis-associated Protein TRPML1
J. Biol. Chem.,
June 23, 2006;
281(25):
17517 - 17527.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Miedel, K. M. Weixel, J. R. Bruns, L. M. Traub, and O. A. Weisz
Posttranslational Cleavage and Adaptor Protein Complex-dependent Trafficking of Mucolipin-1
J. Biol. Chem.,
May 5, 2006;
281(18):
12751 - 12759.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|